Newsable Asianet News on MSN
ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week
Arbutus expects to receive around $179 million from Moderna.
Arbutus (ABUS) looks stronger after Moderna validates its LNP patents, with imdusiran showing durable viral control and a ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Arbutus Biopharma Corp. Annual stock financials by MarketWatch. View the latest ABUS financial statements, income statements and financial ratios.
Stocktwits on MSN
ABUS stock on track for best day in about two months — what’s the Moderna connection?
On July 8, Arbutus received around $178 million from Moderna as part of a patent litigation settlement, the company said.
Arbutus Biopharma (ABUS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results